Zeo ScientifiX, Inc.
Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, osteoarth… Read more
Zeo ScientifiX, Inc. (ZEOX) - Total Liabilities
Latest total liabilities as of October 2025: $2.95 Million USD
Based on the latest financial reports, Zeo ScientifiX, Inc. (ZEOX) has total liabilities worth $2.95 Million USD as of October 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zeo ScientifiX, Inc. - Total Liabilities Trend (2020–2025)
This chart illustrates how Zeo ScientifiX, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zeo ScientifiX, Inc. Competitors by Total Liabilities
The table below lists competitors of Zeo ScientifiX, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The Investment Trust Of India Limited
NSE:THEINVEST
|
India | ₹7.29 Billion |
|
Rapid Dose Therapeutics Corp
PINK:RDTCF
|
USA | $10.43 Million |
|
Remsons Industries Limited
NSE:REMSONSIND
|
India | ₹2.09 Billion |
|
Cloudastructure, Inc. Class A Common Stock
NASDAQ:CSAI
|
USA | $1.89 Million |
|
Galileo Mining Ltd
AU:GAL
|
Australia | AU$653.15K |
|
Ion Video Ltd
AU:IOV
|
Australia | AU$2.81 Million |
|
Vraj Iron and Steel Ltd
NSE:VRAJ
|
India | ₹516.07 Million |
|
NORTHERN FREEGOLD
F:8N6
|
Germany | €405.86K |
Liability Composition Analysis (2020–2025)
This chart breaks down Zeo ScientifiX, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zeo ScientifiX, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zeo ScientifiX, Inc. (2020–2025)
The table below shows the annual total liabilities of Zeo ScientifiX, Inc. from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-10-31 | $2.95 Million | -10.50% |
| 2024-10-31 | $3.30 Million | -18.08% |
| 2023-10-31 | $4.02 Million | -6.70% |
| 2022-10-31 | $4.31 Million | -6.23% |
| 2021-10-31 | $4.60 Million | +68.69% |
| 2020-10-31 | $2.73 Million | -- |